These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4262850)

  • 21. 5-Fluorouracil derivatives. III. A simple method to prepare 5-fluoro-2'-deoxyuridine derivatives.
    Ozaki S; Watanabe Y; Hoshiko T; Ii S; Kagawa T
    Nucleic Acids Symp Ser; 1983; (12):9-12. PubMed ID: 6229716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients.
    Li KM; Rivory LP; Clarke SJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):121-30. PubMed ID: 15866500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorinated pyrimidines. 41. Syntheses of 5-trifluoromethyl-3'-deoxyuridine and 5-fluoro-3'-deoxyuridine.
    Nesnow S; Mian AM; Oki T; Dexter DL; Heidelberger C
    J Med Chem; 1972 Jun; 15(6):676-7. PubMed ID: 4337903
    [No Abstract]   [Full Text] [Related]  

  • 24. A single-step phosphorylation of 5-fluoro-2'-deoxyuridine to 5-fluoro-2'-deoxyuridine 5'-phosphate.
    Chiu TM; Dunlap RB
    J Med Chem; 1974 Sep; 17(9):1029-30. PubMed ID: 4277985
    [No Abstract]   [Full Text] [Related]  

  • 25. The in vitro stability of doxifluridine in whole blood and plasma.
    Schaaf LJ; Dobbs BR; Edwards IR; Perrier DG
    Eur J Clin Pharmacol; 1988; 34(5):533-4. PubMed ID: 2974419
    [No Abstract]   [Full Text] [Related]  

  • 26. On the differential affinities of two anticancer analogues to their target.
    Holl E; Zänker KS; Lange J; Siewert JR
    Drugs Exp Clin Res; 1985; 11(2):133-9. PubMed ID: 2941256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of 5-fluoro-2'-deoxyuridine in plasma by gas chromatography and negative-ion chemical ionization mass spectrometry.
    Sato J; Watanabe K; Takahama S; Makita T
    J Chromatogr; 1992 Mar; 575(1):63-7. PubMed ID: 1387650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3'-O- and 5'-O-Propargyl Derivatives of 5-Fluoro-2'-Deoxyuridine: Synthesis, Cytotoxic Evaluation and Conformational Analysis.
    Baraniak D; Baranowski D; Ruszkowski P; Boryski J
    Nucleosides Nucleotides Nucleic Acids; 2016; 35(4):178-94. PubMed ID: 26914155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-fluorouracil and derivatives in cancer chemotherapy: determination of 5-fluorouracil in blood.
    Windheuser JJ; Sutter JL; Auen E
    J Pharm Sci; 1972 Feb; 61(2):301-3. PubMed ID: 5059811
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
    Iigo M; Nishikata K; Hoshi A
    Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography.
    Schaaf LJ; Ferry DG; Hung CT; Perrier DG; Edwards IR
    J Chromatogr; 1985 Aug; 342(2):303-13. PubMed ID: 2932458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FURTHER CLINICAL COMPARISON BETWEEN 5-FLUOROURACIL (5-FU) AND 5-FLUORO-2' -DEOXYURIDINE (5-FUDR).
    ANSFIELD FJ; CURRERI AR
    Cancer Chemother Rep; 1963 Oct; 32():101-5. PubMed ID: 14088828
    [No Abstract]   [Full Text] [Related]  

  • 33. Pulmonary elimination and metabolism of 5-fluoro-2'-deoxyuridine in isolated perfused rat lung and lung slices.
    Foth H; Hellkamp J; Kunellis EM; Kahl GF
    Drug Metab Dispos; 1990; 18(6):1011-7. PubMed ID: 1981506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gas-liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasma and urine.
    Williams WM; Warren BS; Lin F
    Anal Biochem; 1985 Jun; 147(2):478-86. PubMed ID: 3160256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine as an effector in radiation-activated prodrugs.
    Shibamoto Y; Mimasu Y; Tachi Y; Hatta H; Nishimoto S
    J Chemother; 2002 Aug; 14(4):390-6. PubMed ID: 12420858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorinated pyrimidines. 33. Synthesis of methylated 5-fluoro-2'-deoxyuridine derivatives.
    Khwaja TA; Heidelberger C
    J Med Chem; 1970 Jan; 13(1):64-9. PubMed ID: 4243952
    [No Abstract]   [Full Text] [Related]  

  • 37. 5-Fluoro-5'-deoxyuridine is an inhibitor of uridylate nucleotidase in L1210 leukaemia.
    Roobol C; De Dobbeleer GB; Bernheim JL
    Adv Exp Med Biol; 1986; 195 Pt B():177-83. PubMed ID: 3020904
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of 5-fluoro-2'-deoxyuridine[6-3H] as an impurity in 5-fluoro-uracil[6-3H] by high-performance liquid chromatography.
    Day JL; Maybaum J; Sadée W
    J Chromatogr; 1981 Feb; 206(2):407-9. PubMed ID: 6453879
    [No Abstract]   [Full Text] [Related]  

  • 39. Maintenance of delayed hypersensitivity reactions in patients receiving cancer chemotherapy.
    Liebman IM; Maguire HC
    Acta Derm Venereol; 1968; 48(5):391-6. PubMed ID: 4177561
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
    Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
    Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.